IDEXX Laboratories CEO Presents At 30th Annual JP Morgan Healthcare Conference (Transcript)

IDEXX Laboratories, Inc. (IDXX)

30th Annual JP Morgan Healthcare Conference

January 09, 2012, 17:30 p.m. ET

Executive

Jon Ayers - Chairman, President and CEO

Merilee Raines - Corporate VP and CFO

Presentation

Unidentified Analyst

Compare to:
Previous Statements by IDXX
» IDEXX Laboratories' CEO Discusses Q3 2011 Results - Earnings Call Transcript
» IDEXX Laboratories' CEO Discusses Q2 2011 Results - Earnings Call Transcript
» IDEXX Laboratories Inc. Q4 2008 Earnings Call Transcript

We are going to go ahead and get started. (inaudible) and Diagnostics team. It's my pleasure to introduce our next company, IDEXX Labs. For anyone that’s in the breakout it's going to be across the hall in the Georgia room and let me turn it over to Jon Ayers, to tell you little bit more about the story.

Jon Ayers

Thank you very much. I’m also joined here by Merilee Raines, our Chief Financial Officer, and Merilee and I will be in the breakout room afterwards, really happy to have you all here at the JP Morgan Healthcare Conference.

First of course be familiar with our Safe Harbor statement. Let me change a pace. I hear there are always hundreds of companies presenting at the JP Morgan Healthcare Conference, and all of them but us are I think presenting on the human species and so we are switching track here and talking about some other mammals, that would be dogs and cats and livestock and poultry, generally animal health, a non-human. These are attractive global markets where of course, our big business is in pet healthcare, but we also have other animal health, livestock, and poultry diagnostics. We are big innovator, we are going to talk a little bit about that in both diagnostic and information technology and we had a really great track record over the last couple of decades of consistent top line growth even through the great recession and earnings growth.

1 2 3 Next › Last »